Genetic, biochemical, and clinical features of chronic granulomatous disease

被引:666
作者
Segal, BH [1 ]
Leto, TL [1 ]
Gallin, JI [1 ]
Malech, HL [1 ]
Holland, SM [1 ]
机构
[1] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1097/00005792-200005000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The reduced nicotinamide dinucleotide phosphate (NADPH) oxidase complex allows phagocytes to rapidly convert O2 to superoxide anion which then generates other antimicrobial reactive oxygen intermediates, such as H2O2, hydroxyl anion, and peroxynitrite anion. Chronic granulomatous disease (CGD) results from a defect in any of the 4 subunits of the NADPH oxidase and is characterized by recurrent life-threatening bacterial and fungal infections and abnormal tissue granuloma formation. Activation of the NADPH oxidase requires translocation of the cytosolic subunits p47(phox) (phagocyte oxidase), p67(phox), and the low molecular weight GTPase Rac, to the membrane-bound flavocytochrome, a heterodimer composed of the heavy chain gp91(phox) and the light chain p22(phox). This complex transfers electrons from NADPH on the cytoplasmic side to O2 on the vacuolar or extracellular side, thereby generating superoxide anion. Activation of the NADPH oxidase requires complex rearrangements between the protein subunits, which are in part mediated by noncovalent binding between src-homology 3 domains (SH3 domains) and proline-rich motifs. Outpatient management of CGD patients relies on the use of prophylactic antibiotics and interferon-γ. When infection is suspected, aggressive effort to obtain culture material is required. Treatment of infections involves prolonged use of systemic antibiotics, surgical debridement when feasible, and, in severe infections, use of granulocyte transfusions. Mouse knockout models of CGD have been created in which to examine aspects of pathophysiology and therapy. Gene therapy and bone marrow transplantation trials in CGD patients are ongoing and show great promise.
引用
收藏
页码:170 / 200
页数:31
相关论文
共 443 条
[111]  
DORSEUIL O, 1992, J BIOL CHEM, V267, P20540
[112]   The Rac target NADPH oxidase p67(phox) interacts preferentially with Rac2 rather than Rac1 [J].
Dorseuil, O ;
Reibel, L ;
Bokoch, GM ;
Camonis, J ;
Gacon, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :83-88
[113]  
DOUGHERTY SH, 1983, ARCH SURG-CHICAGO, V118, P873
[114]   Mechanisms of NADPH oxidase activation: Translocation of p40(phox), Rac1 and Rac2 from the cytosol to the membranes in human neutrophils lacking p47(phox) or p67(phox) [J].
Dusi, S ;
Donini, M ;
Rossi, F .
BIOCHEMICAL JOURNAL, 1996, 314 :409-412
[115]   ACTIVATION OF NADPH OXIDASE OF HUMAN NEUTROPHILS INVOLVES THE PHOSPHORYLATION AND THE TRANSLOCATION OF CYTOSOLIC P67PHOX [J].
DUSI, S ;
ROSSI, F .
BIOCHEMICAL JOURNAL, 1993, 296 :367-371
[116]   RELATIONSHIP BETWEEN PHOSPHORYLATION AND TRANSLOCATION TO THE PLASMA-MEMBRANE OF P47PHOX AND P67PHOX AND ACTIVATION OF THE NADPH OXIDASE IN NORMAL AND CA2+-DEPLETED HUMAN NEUTROPHILS [J].
DUSI, S ;
DELLABIANCA, V ;
GRZESKOWIAK, M ;
ROSSI, F .
BIOCHEMICAL JOURNAL, 1993, 290 :173-178
[117]  
Dusi S, 1998, J IMMUNOL, V161, P4968
[118]   Formation of nitric oxide derived inflammatory oxidants by myeloperoxidase in neutrophils [J].
Eiserich, JP ;
Hristova, M ;
Cross, CE ;
Jones, AD ;
Freeman, BA ;
Halliwell, B ;
van der Vliet, A .
NATURE, 1998, 391 (6665) :393-397
[119]   PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91phox expression [J].
Eklund, EA ;
Jalava, A ;
Kakar, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13957-13965
[120]   CHARACTERIZATION OF A GP91-PHOX PROMOTER ELEMENT THAT IS REQUIRED FOR INTERFERON-GAMMA-INDUCED TRANSCRIPTION [J].
EKLUND, EA ;
SKALNIK, DG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :8267-8273